Petar Bajic, MD
Urology · Cleveland, OHNPI 1053653501
Payments from drug & device makers
Across 585 payments — averaging $548.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$191K
- Boston Scientific$52K
- Endo USA, Inc.$30K
- Endo Pharmaceuticals Inc.$25K
- Olympus America Inc.$16K
- Marius Pharmaceuticals, Inc$3K
- plus $3K from 18 others
Across 1 payment — averaging $130,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coloplast$130K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 230 | $191,399 |
| Boston Scientific | 187 | $52,039 |
| Endo USA, Inc. | 19 | $30,007 |
| Endo Pharmaceuticals Inc. | 46 | $25,252 |
| Olympus America Inc. | 37 | $16,105 |
| Marius Pharmaceuticals, Inc | 1 | $3,000 |
| Procept Biorobotics Corporation | 31 | $1,222 |
| Antares Pharma, Inc. | 8 | $284 |
| Dendreon Pharmaceuticals LLC | 3 | $226 |
| Tolmar, Inc. | 6 | $171 |
| Travere Therapeutics, Inc. | 1 | $140 |
| Carl Zeiss Meditec USA, Inc. | 1 | $125 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $124 |
| Teleflex LLC | 1 | $120 |
| Innovation Technologies Inc | 1 | $115 |
| Valencia Technologies Corporation | 1 | $109 |
| Baxter Healthcare | 1 | $89 |
| EDAP Technomed Inc | 1 | $71 |
| Convatec Inc. | 3 | $69 |
| Medtronic | 2 | $40 |
| Johnson & Johnson | 1 | $25 |
| Olympus Corporation Of The Americas | 1 | $22 |
| Neotract Inc. | 1 | $19 |
| 180 Medical, Inc. | 1 | $15 |
How this compares
$320,787 in reported general payments places this provider in the 95th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Cleveland
- Howard GoldmanCleveland$747K
- Jihad KaoukCleveland$696K
- Raymond RackleyCleveland$695K
- Sandip VasavadaCleveland$512K
- Sriharan SivalingamCleveland$282K
- Adonis HijazCleveland$263K
- Ruben OlivaresCleveland$184K
- Ahmed AboumohamedCleveland$139K
- Jorge Gutierrez AcevesCleveland$90K
- Samuel HaywoodCleveland$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.